SPR has officially replaced anti-malaria drug HCQ with anti-parasite drug ivermectin in its covid-19 prophylaxis and early treatment protocol recommended to doctors and authorities. Ivermectin was already listed as an ‘additional component’ of the SPR protocol, but recent controlled randomized trials and large observational studies have confirmed a superior performance, showing covid mortality reductions of... Continue Reading →
Source